PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 93 filers reported holding PMV PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,655,326 | +1.8% | 269,597 | +3.8% | 0.00% | – |
| Q2 2023 | $1,626,611 | +34.5% | 259,842 | +2.5% | 0.00% | – |
| Q1 2023 | $1,209,071 | -44.8% | 253,474 | +0.6% | 0.00% | -100.0% |
| Q4 2022 | $2,192,043 | -25.9% | 251,959 | +1.4% | 0.00% | 0.0% |
| Q3 2022 | $2,957,000 | -2.5% | 248,476 | +16.7% | 0.00% | 0.0% |
| Q2 2022 | $3,034,000 | -25.2% | 212,897 | +9.2% | 0.00% | 0.0% |
| Q1 2022 | $4,058,000 | -7.4% | 194,876 | +2.7% | 0.00% | 0.0% |
| Q4 2021 | $4,384,000 | -21.4% | 189,779 | +1.4% | 0.00% | -50.0% |
| Q3 2021 | $5,578,000 | +42.8% | 187,163 | +63.8% | 0.00% | +100.0% |
| Q2 2021 | $3,905,000 | +39.5% | 114,288 | +34.3% | 0.00% | 0.0% |
| Q1 2021 | $2,799,000 | -45.3% | 85,085 | +2.3% | 0.00% | -50.0% |
| Q4 2020 | $5,116,000 | – | 83,164 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Capital LLC | 4,179,416 | $257,076,000 | 54.42% |
| INTERWEST VENTURE MANAGEMENT CO | 6,469,911 | $397,964,000 | 49.71% |
| Octagon Capital Advisors LP | 250,000 | $15,378,000 | 5.33% |
| Boxer Capital, LLC | 2,268,236 | $139,519,000 | 4.48% |
| COMMODORE CAPITAL LP | 125,000 | $7,689,000 | 4.18% |
| Orbimed Advisors | 7,330,423 | $450,894,000 | 3.95% |
| Asymmetry Capital Management, L.P. | 96,595 | $5,942,000 | 2.71% |
| Avoro Capital Advisors LLC | 2,350,267 | $130,536,000 | 2.25% |
| RA Capital Management | 1,710,265 | $105,198,000 | 1.47% |
| HighVista Strategies LLC | 22,654 | $1,393,000 | 0.89% |